Intermittent cocaine self-Administration produces sensitization of stimulant effects at the dopamine transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 349, Issue 2, 2014, Pages 192-198

  Calipari, Erin S ^a   Ferris, Mark J ^a   Siciliano, Cody A ^a   Zimmer, Benjamin A ^a   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; COCAINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN LEVEL; BRAIN SLICE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DRUG EFFECT; DRUG SELF ADMINISTRATION; DRUG SENSITIZATION; ELECTROENCEPHALOGRAM; FUNCTIONAL ASSESSMENT; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; REWARD; SENSITIZATION; SIGNAL TRANSDUCTION; SPIKE WAVE;

AMPHETAMINE; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; METHYLPHENIDATE; NUCLEUS ACCUMBENS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION;

EID: 84897378061     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.212993     Document Type: Article

References (39)

1. Addy NA, Daberkow DP, Ford JN, Garris PA, and Wightman RM (2010) Sensitization of rapid dopamine signaling in the nucleus accumbens core and shell after repeated cocaine in rats. J Neurophysiol 104:922-931
2. Ahmed SH and Koob GF (2005) Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) 180:473-490
3. Calipari ES, Beveridge TJ, Jones SR, and Porrino LJ (2013a) Withdrawal from extended-Access cocaine self-Administration results in dysregulated functional activity and altered locomotor activity in rats. Eur J Neurosci 38:3749-3757
4. Calipari ES, Ferris MJ, and Jones SR (2014a) Extended access of cocaine selfadministration results in tolerance to the dopamine-elevating and locomotorstimulating effects of cocaine. J Neurochem 128:224-232
5. Calipari ES, Ferris MJ, Melchior JR, Bermejo K, Salahpour A, Roberts DC, and Jones SR (2012) Methylphenidate and cocaine self-Administration produce distinct dopamine terminal alterations. Addict Biol DOI: 10.1111/j.1369-1600. 2012.00456.x [published ahead of print]
6. Calipari ES, Ferris MJ, Salahpour A, Caron MG, and Jones SR (2013b) Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression. Nat Commun 4:2720
7. Calipari ES, Ferris MJ, Zimmer BA, Roberts DC, and Jones SR (2013c) Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter. Neuropsychopharmacology 38: 2385-2392
8. Calipari ES and Jones SR (2014b) Sensitized nucleus accumbens dopamine terminal responses tomethylphenidate and dopamine transporter releasers after intermittentaccess self-Administration. Neuropharmacology DOI: 10.1016/j.neuropharm.2014.02.021
9. Chen N and Reith ME (2007) Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells. J Neurochem 101:377-388
10. Dar DE, Mayo C, and Uhl GR (2005) The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands. Biochem Pharmacol 70:461-469
11. Ferris MJ, Calipari ES, Mateo Y, Melchior JR, Roberts DC, and Jones SR (2012) Cocaine self-Administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate. Neuropsychopharmacology 37:1708-1716
12. Ferris MJ, Calipari ES, Melchior JR, Roberts DC, Espana RA, and Jones SR (2013a) Paradoxical tolerance to cocaine after initial supersensitivity in drug-use-prone animals. Eur J Neurosci 38:2628-2636
13. Ferris MJ, Calipari ES, Yorgason JT, and Jones SR (2013b) Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices. ACS Chem Neurosci 4:693-703
14. Ferris MJ, Mateo Y, Roberts DC, and Jones SR (2011) Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-Administration. Biol Psychiatry 69:201-207
15. Froimowitz M, Patrick KS, and Cody V (1995) Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT. Pharm Res 12:1430-1434
16. Hermans A, Keithley RB, Kita JM, Sombers LA, and Wightman RM (2008) Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction. Anal Chem 80:4040-4048
17. Hirabayashi M, Okada S, and Tadokoro S (1991) Comparison of sensitization to ambulation-increasing effects of cocaine and methamphetamine after repeated administration in mice. J Pharm Pharmacol 43:827-830
18. Hurd YL, Weiss F, Koob GF, And NE, and Ungerstedt U (1989) Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res 498:199-203
19. Jones SR, Garris PA, and Wightman RM (1995) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J Pharmacol Exp Ther 274:396-403
20. Kinsey BM, Kosten TR, and Orson FM (2010) Active immunotherapy for the Treatment of Cocaine Dependence. Drugs Future 35:301-306
21. Lett BT (1989) Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98: 357-362
22. Mateo Y, Lack CM, Morgan D, Roberts DC, and Jones SR (2005) Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge selfadministration and deprivation. Neuropsychopharmacology 30:1455-1463
23. Pan HT, Menacherry S, and Justice JB, Jr. (1991) Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats. J Neurochem 56: 1299-1306
24. Peoples LL, Kravitz AV, Lynch KG, and Cavanaugh DJ (2007) Accumbal neurons that are activated during cocaine self-Administration are spared from inhibitory effects of repeated cocaine self-Administration. Neuropsychopharmacology 32:1141-1158
25. Peoples LL, Lynch KG, Lesnock J, and Gangadhar N (2004) Accumbal neural responses during the initiation and maintenance of intravenous cocaine selfadministration. J Neurophysiol 91:314-323
26. Rao A, Sorkin A, and Zahniser NR (2013) Mice expressing markedly reduced striatal dopamine transporters exhibit increased locomotor activity, dopamine uptake turnover rate, and cocaine responsiveness. Synapse 67:668-677
27. Ritz MC and Kuhar MJ (1989) Relationship between self-Administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010-1017
28. Roberts DC, Corcoran ME, and Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-Administration of cocaine. Pharmacol Biochem Behav 6:615-620
29. Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E, Ghisi V, Nicholls PJ, Wong L, and Murphy K, et al. (2008) Increased amphetamineinduced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci USA 105:4405-4410
30. Santagati NA, Ferrara G, Marrazzo A, and Ronsisvalle G (2002) Simultaneous determination of amphetamine and one of its metabolites by HPLC with electrochemical detection. J Pharm Biomed Anal 30:247-255
31. Schmitt KC, Rothman RB, and Reith ME (2013) Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates. J Pharmacol Exp Ther 346:2-10
32. Schmitt KC, Zhen J, Kharkar P, Mishra M, Chen N, Dutta AK, and Reith ME (2008) Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties. J Neurochem 107: 928-940
33. Stuber GD, Roitman MF, Phillips PE, Carelli RM, and Wightman RM (2005a) Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration. Neuropsychopharmacology 30: 853-863
34. Stuber GD, Wightman RM, and Carelli RM (2005b) Extinction of cocaine selfadministration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. Neuron 46:661-669
35. Tilley MR, O'Neill B, Han DD, and Gu HH (2009) Cocaine does not produce reward in absence of dopamine transporter inhibition. Neuroreport 20:9-12
36. Wayment HK, Deutsch H, Schweri MM, and Schenk JO (1999) Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists? J Neurochem 72:1266-1274
37. Wise RA, Newton P, Leeb K, Burnette B, Pocock D, and Justice JB, Jr. (1995) Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-Administration in rats. Psychopharmacology (Berl) 120:10-20
38. Yorgason JT, Espana RA, and Jones SR (2011) Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202:158-164
39. Zimmer BA, Oleson EB, and Roberts DCS (2012) Themotivation to self-Administer is increased after a history of spiking brain levels of cocaine. Neuropsychopharmacology 37:1901-1910.